Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-24 @ 10:57 PM
NCT ID:
NCT02943369
Eligibility Criteria:
Inclusion Criteria:
* Consecutive P2Y12 inhibitor-naive STEMI patients with pain onset\<12 hours admitted for primary PCI.
Exclusion Criteria:
* a history of stroke/transient ischemic attack
* bleeding diathesis
* chronic oral anticoagulation treatment
* contraindications to anti platelet therapy
* PCI or coronary artery bypass grafting \<3 months
* platelet count \<100 000/μL
* hematocrit \<30%
* creatinine clearance \<30 mL/min
* severe hepatic dysfunction
* use of strong CYP3A inhibitors or inducers
* increased risk of bradycardia
* severe chronic obstructive pulmonary disease
* periprocedural IIb/IIIa inhibitor administration.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
90 Years
Study:
NCT02943369
Study Brief:
Protocol Section:
NCT02943369